A Study Using Medical Records of Danish People With Type 2 Diabetes Comparing Empagliflozin and Glucagon-Like Peptide-1 Receptor Agonists (GLP1-RA) in the Occurrence of Serious Cardiovascular Outcomes
Clinical trial NCT03993132 · COMPLETED
Trial details
- NCT number
- NCT03993132
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-10-01
- Primary completion
- 2022-06-16
- Enrollment
- 26774
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.